MétaCan
Menu
← Back to cohort
Record W2922444928 · doi:10.1002/jbm4.10136

Mechanistic and Therapeutic Advances in Rare Skeletal Diseases Meeting, September 26–27, 2018: A Meeting in Affiliation With the American Society for Bone and Mineral Research (ASBMR)

2019· article· en· W2922444928 on OpenAlexaboutno aff
Brendan Lee, Maurizio Pacifici, Struan F.A. Grant, Yingzi Yang, Ruoshi Xu, Xuedong Zhou, Eduardo Calpena, Kerry A. Miller, Yan Zhou, David Johnson, Steven A. Wall, Stephen R.F. Twigg, Andrew O.M. Wilkie, Ophir D. Klein, Yuxing Guo Yuan, Yang Chai, Sandesh C.S. Nagamani, Dianne Dang, Ingo Grafe, Eric Orwoll, Catherine Pedersen, Reid Sutton, Andreas Grauer, C. Galateanu, Rachel B. Wagman

Bibliographic record

VenueJBMR Plus · 2019
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicConnective tissue disorders research
Canadian institutionsnot available
FundersNational Center for Advancing Translational SciencesNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Institute on AgingNational Institute of Dental and Craniofacial ResearchSanofi GenzymeSoft BonesAlexion PharmaceuticalsUltragenyx PharmaceuticalRegeneron PharmaceuticalsSanofi
KeywordsMedicineLibrary scienceFamily medicineComputer science

Abstract

fetched live from OpenAlex

A rare disease in the US is defined as a condition that affects fewer than 200,000 Americans.Similar numerical definitions are found in other countries with the vast majority of them being caused by genetic mutations that are transmitted in Mendelian fashion.Increasingly powerful genomic technologies such as next-generation sequencing have led to the identification of close to 4000 disease-associated genes and more than 7000 phenotypes associated with mutations in these genes.The following collection of abstracts were presented in the recent conference co-organized by the Rare Bone Diseases Alliance, the Osteogenesis Imperfecta Foundation, and the Brittle Bone Disorders Consortium of the NIH Rare Diseases Clinical Research Consortia on the Mechanistic and Therapeutic Advances of Rare Skeletal Diseases on September 26-27 in Montreal, Canada.The purpose of the conference, held in partnership with the American Society for Bone and Mineral Research Annual Meeting, was to bring together clinicians and basic, translational, and clinical researchers interested in rare genetic disorders affecting the skeleton and to provide a forum for state-of-the-art talks on the current state of diagnosis, preclinical models and mechanistic basis of disease, therapeutic strategies in the clinical arena, and novel endpoints and assessments.The initial session focused on diagnostic approaches to rare skeletal diseases ranging from classical radiographic and ultrasonographic approaches to multi-omic approaches based on next-generation DNA sequencing, RNA sequencing, and metabolomics; evaluation of chromatin architecture in controlling gene expression in the context of translating rare genetic mutation to common bone phenotypes; and finally, analysis of protein modifications of macromolecules such as collagens in the pathogenesis of bone disease.These talks underscored the importance of multidimensional approaches to phenotyping

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Other · Consensus signal: none
Teacher disagreement score0.051
Threshold uncertainty score0.170

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0020.002
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0000.001
Bibliometrics0.0010.000
Science and technology studies0.0010.000
Scholarly communication0.0020.001
Open science0.0010.002
Research integrity0.0020.004
Insufficient payload (model declined to judge)0.0510.020

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.016
GPT teacher head0.331
Teacher spread0.315 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreOther

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2019
Admission routes1
Has abstractyes

Explore more

Same venueJBMR Plus→Same topicConnective tissue disorders research→French-language works237,207→